New drug could reduce damage to brain cells linked to Parkinson’s symptoms
Date
New research suggests that severe head injury, which causes loss of consciousness, could be linked to increased risk of developing Parkinson's.
7 of the world’s largest pharmaceutical companies have signed up to a ground-breaking new initiative to improve clinical trials for Parkinson's.
Researchers at the University of Bristol have discovered that a common dementia drug, rivastigmine, could reduce falls in people with Parkinson's.